Finance

Lists
Why is DCGO down 2.79%?
Dive Deeper
DCGO:NASDAQ
DocGo Inc
$0.35
-2.79%
(-0.010) 1D
Oct 7, 11:59:09 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DCGO...
Open
$0.35
High
$0.36
Low
$0.35
Mkt. cap
35.01M
Avg. vol.
667.87K
Volume
146.58K
52-wk high
$1.65
52-wk low
$0.31
EPS
-$1.96
Beta
0.97
Shares outstanding
98.93M
No. of employees
3K
Open
$0.35
High
$0.36
Low
$0.35
Mkt. cap
35.01M
Avg. vol.
667.87K
Volume
146.58K
52-wk high
$1.65
52-wk low
$0.31
EPS
-$1.96
Beta
0.97
Shares outstanding
98.93M
No. of employees
3K
News stories
From web sources and news partners
Profile
DocGo is a mobile healthcare company founded in 2015 as Ambulnz, and is now traded on the NASDAQ. The company specializes in mobile health services and medical transportation. Wikipedia
About DocGo Inc
CEO-
Employees3.05K
Founded2015
Headquarters-
SectorHealth care provider
Websitedocgo.com
Analyst ratings
Based on 4 analysts giving stock ratings to DCGO in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for DCGO in the last 3 months.
Highest
Current $0.35
$3.00 (+752.51%)
Average
$2.17 (+516.65%)
Lowest
$1.00 (+184.17%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Larsen
BTIG
Hold
Reiterated
-
-
09/30/2026
Ryan MacDonald
Needham
Buy
Reiterated
$3.00
+752.5%
09/30/2026
David Grossman
Stifel Nicolaus
Buy
Maintained
$2.50
+610.4%
08/18/2026
Richard Close
Canaccord Genuity
Hold
Maintained
$1.00
+184.2%
08/18/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
$3.00
+752.5%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
70.81M
74.94M
75.55M
73.42M
Cost of goods sold
52.68M
50.57M
51.67M
51.02M
Cost of revenue
52.68M
50.57M
51.67M
51.02M
Research and development expenses
3.19M
3.77M
3.71M
3.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36.20M
49.09M
36.24M
34.19M
Operating expense
43.36M
56.81M
42.59M
40.33M
Total operating expenses
96.05M
107.38M
94.26M
91.35M
Operating income
-25.24M
-32.44M
-18.71M
-17.92M
Other non operating income
104.09K
-424.25K
264.96K
123.04K
EBT including unusual items
-43.17M
-111.61M
-16.68M
-17.94M
EBT excluding unusual items
-25.38M
-33.46M
-18.55M
-17.90M
Income tax expense
-13.51M
30.73M
19.28K
56.13K
Effective tax rate
31.30%
-27.53%
-0.12%
-0.31%
Other operating expenses
-
-
-
-
Net income
-27.77M
-134.07M
-14.76M
-15.82M
Net profit margin
-39.22%
-178.91%
-19.54%
-21.55%
Earnings per share
-
-
-
-
Interest and investment income
-
730.50K
153.40K
155.98K
Interest expense
-219.86K
-882.86K
-253.13K
-253.57K
Net interest expenses
-219.86K
-152.35K
-99.73K
-97.58K
Depreciation and amortization charges
3.97M
3.95M
2.65M
2.69M
EBITDA
-21.27M
-28.49M
-16.06M
-15.23M
Gain or loss from assets sale
10.45K
-4.00K
62.49K
39.57K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps